Logo image of IPA

IMMUNOPRECISE ANTIBODIES LTD (IPA) Stock Overview

NASDAQ:IPA - CA45257F2008 - Common Stock

2.07 USD
+0.14 (+7.25%)
Last: 9/3/2025, 8:24:29 PM
2.12 USD
+0.05 (+2.42%)
After Hours: 9/3/2025, 8:24:29 PM

IPA Key Statistics, Chart & Performance

Key Statistics
52 Week High3.25
52 Week Low0.27
Market Cap95.53M
Shares46.15M
Float41.92M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.22
PEN/A
Fwd PEN/A
Earnings (Next)09-11 2025-09-11
IPO01-30 1987-01-30
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services


IPA short term performance overview.The bars show the price performance of IPA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 100 200 300 400

IPA long term performance overview.The bars show the price performance of IPA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 100 150 200

The current stock price of IPA is 2.07 USD. In the past month the price increased by 14.36%. In the past year, price increased by 209.19%.

IMMUNOPRECISE ANTIBODIES LTD / IPA Daily stock chart

IPA Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 22.5 186.01B
DHR DANAHER CORP 26.59 143.36B
A AGILENT TECHNOLOGIES INC 23.62 36.57B
IQV IQVIA HOLDINGS INC 16.36 31.91B
MTD METTLER-TOLEDO INTERNATIONAL 31.92 26.90B
WAT WATERS CORP 25.05 18.23B
WST WEST PHARMACEUTICAL SERVICES 36.02 18.03B
ILMN ILLUMINA INC 23.78 15.21B
TEM TEMPUS AI INC N/A 13.83B
MEDP MEDPACE HOLDINGS INC 36.21 13.68B
ICLR ICON PLC 13.22 13.60B
QGEN QIAGEN N.V. 20.23 10.31B

About IPA

Company Profile

IPA logo image ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The company is headquartered in Austin, Texas. The company is advancing Bio-Native AI at the intersection of biology and computation. Its LENSai and HYFT platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology. The core of its operations encompasses a diverse suite of proprietary technologies that aid in the exploration, discovery, and development of novel drugs and biologics. Integrated within its wet lab infrastructure is a diverse array of in silico technologies. As an end-to-end service provider of antibody discovery and development, its computational methodologies allow the Company to perform detailed and comprehensive evaluations across various stages of biologic discovery and development. The company is involved in antibody characterization studies, which encompass affinity measurements, epitope landscape profiling, and others.

Company Info

IMMUNOPRECISE ANTIBODIES LTD

Industrious 823 Congress Ave Suite 300

Austin TEXAS US

Employees: 87

IPA Company Website

IPA Investor Relations

Phone: 16048060626

IMMUNOPRECISE ANTIBODIES LTD / IPA FAQ

What is the stock price of IMMUNOPRECISE ANTIBODIES LTD today?

The current stock price of IPA is 2.07 USD. The price increased by 7.25% in the last trading session.


What is the ticker symbol for IMMUNOPRECISE ANTIBODIES LTD stock?

The exchange symbol of IMMUNOPRECISE ANTIBODIES LTD is IPA and it is listed on the Nasdaq exchange.


On which exchange is IPA stock listed?

IPA stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for IMMUNOPRECISE ANTIBODIES LTD stock?

6 analysts have analysed IPA and the average price target is 5.1 USD. This implies a price increase of 146.38% is expected in the next year compared to the current price of 2.07. Check the IMMUNOPRECISE ANTIBODIES LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is IMMUNOPRECISE ANTIBODIES LTD worth?

IMMUNOPRECISE ANTIBODIES LTD (IPA) has a market capitalization of 95.53M USD. This makes IPA a Micro Cap stock.


How many employees does IMMUNOPRECISE ANTIBODIES LTD have?

IMMUNOPRECISE ANTIBODIES LTD (IPA) currently has 87 employees.


What are the support and resistance levels for IMMUNOPRECISE ANTIBODIES LTD (IPA) stock?

IMMUNOPRECISE ANTIBODIES LTD (IPA) has a support level at 1.92. Check the full technical report for a detailed analysis of IPA support and resistance levels.


Is IMMUNOPRECISE ANTIBODIES LTD (IPA) expected to grow?

The Revenue of IMMUNOPRECISE ANTIBODIES LTD (IPA) is expected to grow by 13.46% in the next year. Check the estimates tab for more information on the IPA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy IMMUNOPRECISE ANTIBODIES LTD (IPA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does IMMUNOPRECISE ANTIBODIES LTD (IPA) stock pay dividends?

IPA does not pay a dividend.


When does IMMUNOPRECISE ANTIBODIES LTD (IPA) report earnings?

IMMUNOPRECISE ANTIBODIES LTD (IPA) will report earnings on 2025-09-11.


What is the Price/Earnings (PE) ratio of IMMUNOPRECISE ANTIBODIES LTD (IPA)?

IMMUNOPRECISE ANTIBODIES LTD (IPA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.22).


What is the Short Interest ratio of IMMUNOPRECISE ANTIBODIES LTD (IPA) stock?

The outstanding short interest for IMMUNOPRECISE ANTIBODIES LTD (IPA) is 1.03% of its float. Check the ownership tab for more information on the IPA short interest.


IPA Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to IPA. When comparing the yearly performance of all stocks, IPA is one of the better performing stocks in the market, outperforming 98.69% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IPA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to IPA. IPA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IPA Financial Highlights

Over the last trailing twelve months IPA reported a non-GAAP Earnings per Share(EPS) of -0.22. The EPS increased by 34.78% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -68.03%
ROE -127.97%
Debt/Equity 0.49
Chartmill High Growth Momentum
EPS Q2Q%54.55%
Sales Q2Q%8.08%
EPS 1Y (TTM)34.78%
Revenue 1Y (TTM)0.01%

IPA Forecast & Estimates

6 analysts have analysed IPA and the average price target is 5.1 USD. This implies a price increase of 146.38% is expected in the next year compared to the current price of 2.07.

For the next year, analysts expect an EPS growth of 49.5% and a revenue growth 13.46% for IPA


Analysts
Analysts80
Price Target5.1 (146.38%)
EPS Next Y49.5%
Revenue Next Year13.46%

IPA Ownership

Ownership
Inst Owners8.61%
Ins Owners1.19%
Short Float %1.03%
Short Ratio0.24